Ebrahimi, Niloufar
Geetha, Duvuru
Reyes-Bahamonde, Joselyn
Zuppan, Craig W.
Abdipour, Amir
Norouzi, Sayna https://orcid.org/0000-0001-9912-4959
Funding for this research was provided by:
Loma Linda University
Article History
Received: 21 May 2024
Accepted: 13 July 2025
First Online: 8 August 2025
Change Date: 26 August 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40620-025-02408-0
Declarations
:
: Dr. Sayna Norouzi is on the speaker bureau for Calliditas Therapeutics. She is also a consultant for Calliditas Therapeutics and Otsuka Pharmaceutical Co.
: Informed consent was obtained from the participant included in the study.
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.